Response to ‘Icodextrin lowers serum sodium in dose-dependent fashion: A case report’: Keep calm and continue icodextrin

Abstract

Get full access to this article

View all access options for this article.

References

Karakadze

Sugar

Teitelbaum

. Icodextrin lowers serum sodium in dose-dependent fashion: a case report. Perit Dial Int 2026; 46: 404–407.

Goossen

Becker

Marshall

, et al. Icodextrin versus glucose solutions for the once-daily long dwell in peritoneal dialysis: an enriched systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 2020; 75: 830–846.

Bravo González-Blas

García-Gago

Astudillo-Jarrín

, et al. Analysis of factors influencing the prognostic significance of hyponatremia in peritoneal dialysis patients. Am J Nephrol 2020; 51: 54–64.

Teitelbaum

Zhao

, et al. Associations between serum sodium, peritoneal dialysis-associated peritonitis, and mortality in the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis 2025; 86: 84–96.e1.

Goffin

Béchade

Courivaud

, et al. The double-icodextrin dose randomized controlled trial of a double icodextrin dose for older patients on incremental continuous ambulatory peritoneal dialysis. Kidney Int Rep 2025; 10: 2585–2596.

Dimitriadis

Sekercioglu

Pipili

, et al. Hyponatremia in peritoneal dialysis: epidemiology in a single center and correlation with clinical and biochemical parameters. Perit Dial Int 2014; 34: 260–270.